...
首页> 外文期刊>Emerging Infectious Diseases >Genomic Characterization of Recrudescent Plasmodium malariae after Treatment with Artemether/Lumefantrine
【24h】

Genomic Characterization of Recrudescent Plasmodium malariae after Treatment with Artemether/Lumefantrine

机译:蒿甲醚/卢美他汀治疗后复发性疟原虫的基因组特征

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Plasmodium malariae is the only human malaria parasite species with a 72-hour intraerythrocytic cycle and the ability to persist in the host for life. We present a case of a P. malariae infection with clinical recrudescence after directly observed administration of artemether/lumefantrine. By using whole-genome sequencing, we show that the initial infection was polyclonal and the recrudescent isolate was a single clone present at low density in the initial infection. Haplotypic analysis of the clones in the initial infection revealed that they were all closely related and were presumably recombinant progeny originating from the same infective mosquito bite. We review possible explanations for the P. malariae treatment failure and conclude that a 3-day artemether/lumefantrine regimen is suboptimal for this species because of its long asexual life cycle.
机译:疟原虫是人类唯一的疟疾寄生虫,具有72小时的红细胞内循环,并且能够在宿主体内终生存在。我们提出一例直接观察到蒿甲醚/ lumantantrine给药后临床复发的疟原虫的感染情况。通过使用全基因组测序,我们显示初始感染是多克隆的,而复发分离株是在初始感染中低密度存在的单个克隆。对最初感染中克隆的单倍型分析显示,它们都密切相关,并且大概是源自相同感染蚊虫叮咬的重组后代。我们回顾了对疟疾疟疾治疗失败的可能解释,并得出结论,由于该物种的无性生命周期较长,因此对其进行为期3天的蒿甲醚/荧光粉疗法是次优的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号